The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Fluvoxamine Maleate
Fluvoxamine Maleate · FLUVOXAMINE MALEATE 100 mg/1 · Tablet · Oral · Preferred Pharmaceuticals Inc.
NDC 68788-8175-03 · 30 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 60505-0166-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.5125per unit
middle half $0.3766–$0.6575 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.5125
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 2 · prior auth 0% · step therapy 0% · qty limit 37%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 2 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for fluvoxamine maleate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Preferred Pharmaceuticals Inc.United Statesrepack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA075902
- TE code
- AB
- Approval date
- May 7, 2001
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fluvoxamine Maleate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | FLUVOXAMINE MALEATE 100 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | FLUVOXAMINE MALEATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | FLUVOXAMINE MALEATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp | FLUVOXAMINE MALEATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp | FLUVOXAMINE MALEATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp | FLUVOXAMINE MALEATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bionpharma Inc. | FLUVOXAMINE MALEATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bionpharma Inc. | FLUVOXAMINE MALEATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bionpharma Inc. | FLUVOXAMINE MALEATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | FLUVOXAMINE MALEATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | FLUVOXAMINE MALEATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | FLUVOXAMINE MALEATE 100 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fluvoxamine Maleate — NDC 68788-8175-03," retrieved September 3, 2026, https://drugdashboards.com/drug/68788817503.
Free to cite with attribution — see how the data is put together.